July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Ocular manifestation of Posterior Cortical Atrophy
Author Affiliations & Notes
  • Lajos Csincsik
    School of Medicine, Dentistry and Biomedical Sciences, Queen`s University Belfast, Belfast, United Kingdom
  • Timothy Shakespeare
    Dementia Research Centre, UCL Institute of Neurology, London, United Kingdom
  • Sebastian Crutch
    Dementia Research Centre, UCL Institute of Neurology, London, United Kingdom
  • Tunde Peto
    Queen`s University Belfast, Belfast, United Kingdom
  • Imre Lengyel
    School of Medicine, Dentistry and Biomedical Sciences, Queen`s University Belfast, Belfast, United Kingdom
  • Footnotes
    Commercial Relationships   Lajos Csincsik, OPTOS plc (F); Timothy Shakespeare, None; Sebastian Crutch, None; Tunde Peto, None; Imre Lengyel, None
  • Footnotes
    Support  OPTOS plc unrestricted grant
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 1130. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Lajos Csincsik, Timothy Shakespeare, Sebastian Crutch, Tunde Peto, Imre Lengyel; Ocular manifestation of Posterior Cortical Atrophy. Invest. Ophthalmol. Vis. Sci. 2018;59(9):1130.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Posterior Cortical Atrophy (PCA) is a neurodegenerative syndrome that is characterized by progressive degeneration of parietal and occipital lobe with associated cortical visual impairment, but whether there are changes in the retina in PCA was not known. The most common cause of PCA is Alzheimer`s disease (AD). Retinal nerve fibre layer (RNFL) atrophy, changes in retinal vessel calibres and an increase in drusen deposition has been associated with typical AD (tAD). In this study, we examined images of the retina of patients with PCA and compare these to tAD and healthy controls (HC).

Methods : Ultra-wide-field colour and autofluorescence images (UWFI) and optical coherence tomography (OCT) scans were acquired of 33 PCA (MMSE<24), 28 tAD (MMSE<20) patients and 71 HC (MMSE>28) using OPTOS P200Tx scanning laser ophthalmoscope (SLO) and OPTOS OCT-SLO. Images with poor quality were removed from analysis. The study had full local Ethical Committee approval. UWFI were graded for absence/presence of pathological abnormalities. OCT scans were analysed for macular volume and thickness of retinal layers, whole retinal thickness as well as peripapillary vessel calibre (ppVC) using OPTOS OCT Viewer (v1.89) and OCTseg (v0.4) softwares. Statistical analysis was carried out using STATA and SPSS.

Results : UWFI detected lower prevalence of reticular pseudodrusen in PCA (10%) than in tAD (30%) or HC (17%) [χ2=6.879, df=2, p=0.032]. There was a lower prevalence of far-peripheral hyper-fluorescence changes in tAD (24%) compared to PCA (44%) or HC (43%) [χ2=5.736, df=2, p=0.057]. More tortuous retinal vasculature was observed in tAD (45%) compared to PCA (22%) or HC (18%) [χ2=15.545, df=2, p<0.001]. Analysis of OCT scans showed a significant reduction in peripapillary outer plexiform-inner nuclear layer thickness in patients with PCA compared to HC (64.15µm±7.45µm vs 68.7µm ±9.45µm, p=0.049) and a significant increase in total ppVC in both PCA (457.05µm ±89.85µm) and tAD (478.4µm±83.4) compared to HC (411.15µm ±82.75µm) (p<0.05).

Conclusions : Analysis of retinal images highlighted that there are ocular manifestations of both PCA and tAD suggesting that there might be additional value in detailed grading of retinal imaging in dementia.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×